In a memo to Dr Walford, Dr Oliver (DHSS) expressed the opinion that the assurance from pharmaceutical companies that future sales after June 1983 would comply with FDA guidelines was vague.
Chronology Information
Date:
Chapter/issue
Blood Products and Addressing Risk: Regulation of Commercial Factor Concentrates
Key Person(s)
Dr Diana Walford